Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001170918-07-000174

Options or other derivatives

  • Director acquired 7,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Regenstein Barry Director 2007-02-16 Grant or award · Options to Purchase Common Stock +7,500,000 7,500,000 D
Loading xslF345X02/sam07-064_ex.xml…